10 Micro-, Small-Cap Firms Were Last Week’s Top Performers

3. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Tonix Pharmaceuticals saw its share price surge by 65.6 percent week-on-week to end Friday at $13.02 versus $7.86 on February 28 as investors bought up shares ahead of an investor summit next week.

Investors repositioned portfolios following news that TNXP would present at the 2025 Virtual Investor Summit on Tuesday, March 11, where they would closely look out for cues and updates on its TNX-102 SL, a priority product candidate that aims to manage fibromyalgia.

TNXP said it expects to receive the decision of the Food and Drug Administration on the marketing authorization of the product on August 15, 2025.

Apart from TNX-102 SL, its portfolio also includes TNX-1300, a biologic in Phase 2 development designed to treat cocaine intoxication.